Semen hyperviscosity delays the liquefaction of semen sample and is subjected to limited proteolysis by addition of a-chymotrypsin to reduce the viscosity. a-Chymotrypsin is a proteolytic enzyme involved in degradation of the proteins and polypeptides. Even though a-chymotrypsin improves the handling of hyperviscous samples, its effect on the sperm proteins is not clear. This study was aimed to evaluate the alteration in the expression of sperm functional proteins in samples treated with a-chymotrypsin. Among all the proteins examined in both donor and patient samples, HSPA2 (70 KDa), BAG6 (150 KDa), HIST1H2BA (14 KDa), SPA17 (17 KDa formed after cleavage of C-terminal calmodulin-binding domain), and OXPHOS complexes were undetectable in a-chymotrypsintreated samples, while the expression of the native SPA17 (20 KDa) was significantly decreased in the a-chymotrypsin-treated samples in comparison with controls. The use of a-chymotrypsin for liquefaction of hyperviscous samples degrades functional proteins of spermatozoa. Intracellular proteins, such as OXPHOS complexes and HIST1H2BA, and sperm surface proteins (HSPA2, BAG6, and SPA17) were degraded in all treated samples. Whether treatment of samples with a-chymotrypsin affects the global proteomic outcome is unclear. More in-depth calibration studies are required to determine the appropriate concentration of a-chymotrypsin for processing hyperviscous semen samples without compromising its protein expression and function. Similarly, the effects of altered protein function on assisted reproductive techniques (ART), such as intrauterine insemination (IUI) and in vitro fertilization (IVF) outcome, are not known and require further research.
INTRODUCTION
Human semen coagulates immediately after ejaculation and entraps the spermatozoa in a matrix formed by the seminal plasma proteins. However, it usually liquefies in about 15 to 20 min both in vitro and in vivo (Robert & Gagnon, 1999) . The process of liquefaction is affected by the partial or incomplete proteolysis of seminal plasma proteins present in the coagulum (Emami et al., 2009) . Semen hyperviscosity (SHV) is addressed as one of the factors pertaining to male infertility. It affects about 12% to 29% of patients with male infertility (Du . SHV has adverse effects on the physical and biochemical characteristics of seminal fluid (Gonzales et al., 1993) . It has also a negative effect on vital sperm parameters such as motility and morphology. Incomplete liquefaction of the semen exhibits a trapping effect that hinders the forward sperm movement (Elzanaty et al., 2004) having a negative impact on fertility (Du .
Routine semen analysis is the first step in the laboratory evaluation of male infertility. Complete liquefaction of the semen sample is important as it ensures that the ejaculate can be accurately tested for various semen parameters and second that the spermatozoa are not trapped in the coagulum in case the sample fails to liquefy completely. Among the various causes of SHV, oxidative stress and reactive oxygen species play a major role and pose a challenge during the preparation of sperm samples for IUI and IVF resulting in the complete absence or poor sperm recovery (Honea et al., 1993; Elia et al., 2009; Du Plessis et al., 2013) . Although different methods are proposed to treat SHV, generally hyperviscous samples are subjected to limited proteolysis by the addition of a mucolytic agent, a-chymotrypsin (EC 3.4.21.1) (5%) to reduce the viscosity (Honea et al., 1993; Zavos & Correa, 1997) . It is a well-known fact that proteolytic property of a-chymotrypsin breaks the proteins and polypeptides (Tsiatsiani & Heck, 2015; Giansanti et al., 2016) . Human spermatozoa exhibit a-chymotrypsin-like activity during the acrosome reaction (Morales et al., 1994) . Several studies have reported that achymotrypsin does not have a harmful effect on sperm motility or viability Xu et al., 2006; Agarwal et al., 2016) and that it does not alter the concentration of the total proteins present in the seminal plasma (Mendeluk et al., 2000) . Still, one cannot ignore the fact that treatment with a-chymotrypsin may damage or degrade the sperm proteins. However, no study has examined the effect of a-chymotrypsin at the subcellular level, especially on the sperm surface and intracellular proteins. Thus, the aim of our study was to check the effect of achymotrypsin on the expression of sperm proteins involved in sperm function, such as acrosome reaction, sperm-egg recognition, and oocyte-zona pellucida binding, along with mitochondrial electron transport chain proteins involved in ATP synthesis required for sperm motility.
MATERIALS AND METHODS

Study samples
Following the approval of the study by the Institutional Review Board (IRB) of Cleveland Clinic, semen samples were obtained from healthy male donors (n = 8) of unproven fertility presenting with normal semen parameters (WHO, 2010) and infertile patients (n = 3). They were the partners of spouses who were being evaluated by the gynecologist and sent to the Andrology Center for initial semen evaluation before being referred to a male infertility specialist. Semen samples were collected by masturbation after sexual abstinence of at least 48 h. Round cell concentration was determined in all samples on a wet smear as per WHO 2010 guidelines. Samples with round cell concentration >1 9 10 6 /mL were tested for white blood cell count by the peroxidase or the Endtz test (WHO, 2010) . The inclusion criteria were semen sample volume ≥1.5 mL and negative for leukocytospermia (<1 9 10 6 white blood cells/mL).
Measurement of semen viscosity
Viscosity of each sample was measured qualitatively as per WHO 2010 criteria. Each sample was collected in a wide-mouth sterile collection cup and kept at 37°C for complete liquefaction. The viscosity was examined before transferring the sample from the collection cup into a graduated 15-mL centrifuge tube by gently aspirating the sample into a wide-bore, 5-mL serological pipette and allowing the semen to drop by gravity. If, at the end of incubation, the sample was completely liquefied, that is it did not form threads >2 cm, the sample was graded as completely liquefied with a normal viscosity. If the sample was not completely liquefied, it was categorized as incomplete liquefaction and considered as viscous. Viscosity was categorized as follows: slight viscosity: drops with thread formation (length of thread >2 cm and ≤4 cm); moderate viscosity: thread length (>4 cm and ≤6 cm); and high viscosity: sample fails to drip at all and stays as a coagulum. Samples displaying moderate and high viscosity were categorized as hyperviscous.
a-Chymotrypsin treatment
Experiment 1
Eight semen samples from four donors collected on two different days (~1 month apart) showed different grades of viscosity.
They were categorized into hyperviscous (n = 4) and normal samples (n = 4). Hyperviscous samples were treated with 5 mg of lyophilized a-chymotrypsin powder (viscosity treatment system; VTS, Vitrolife, San Diego, CA). The entire content of the vial was added to the collection cup. The sample was swirled and vortexed quickly and then incubated for additional 20 min for complete liquefaction.
Non-viscous samples were processed according to standard protocols.
Experiment 2
Each non-viscous semen sample from four donors and three infertile patients was split into two aliquots (control and treated) after natural liquefaction. Semen samples from treated group were incubated with 5 mg of lyophilized a-chymotrypsin (Vitrolife, San Diego, CA, USA) for 20 min at 37°C. The concentration of a-chymotrypsin was used according to manufacturer's instructions for hyperviscous samples as mentioned in experiment 1.
Protein selection criteria
A thorough literature search was carried out to select the sperm surface proteins most commonly related to infertility, HSPA2, BAG6, and SPA17, the latter being localized over the acrosome region of the head (Kong et al., 1995; Bromfield et al., 2015; Intasqui et al., 2017) . We selected HIST1H2BA and four mitochondrial proteins involved in oxidative phosphorylation (OXPHOS) along with the cytoskeletal protein a-tubulin involved in sperm motility to check the effect of a-chymotrypsin on the intracellular proteins. All these proteins play an important role in sperm function.
Protein extraction
After the incubation period, all samples were centrifuged at 300g for 7 min and the seminal plasma was removed. The sperm pellet was then washed twice with PBS (phosphate buffer saline) to remove the residual a-chymotrypsin and seminal plasma from the sample. Subsequently, the sperm pellet was resuspended in 1 mL of PBS and sperm concentration was determined prior to storage. Finally, all samples were stored at À80°C for protein expression analysis.
Frozen samples were thawed at 37°C for 20 min and centrifuged at 1000g for 10 min. Based on the predetermined sperm concentration in each vial, spermatozoa were lysed overnight at 4°C with radioimmunoprecipitation assay (RIPA) lysis buffer containing the complete protease inhibitor cocktail (Roche, Mannheim, Germany) using 100 lL of buffer for 100 9 10 6 spermatozoa. After centrifugation at 10,000g for 30 min at 4°C, supernatant was transferred to fresh microcentrifuge tube and protein concentration was estimated by the bicinchoninic acid assay (BCA) kit (Thermo Fisher Scientific, Rockford, IL, USA).
SDS-PAGE and Western blotting analysis
After quantification, each sample was mixed with sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer, denatured at 100°C for 5 min and resolved (20 lg/well) on a 4%-15% gel (Bio-Rad, Hercules, CA, USA). Electrophoresis was performed at constant voltage (90 V) for 120 min at 4°C. The gels were briefly washed with distilled water and proteins were transferred to polyvinylidene difluoride 346 Andrology, 2018, 6, 345-350 (PVDF) membranes (Thermo Fisher, Rockford, IL, USA) at 20 V for 50 min using a Trans-Blotâ SD Semi-Dry Electrophoretic Transfer Cell (Bio-Rad, Hercules, CA, USA). PVDF membranes were blocked with TBST containing 5% BSA and used for immunodetection of sperm proteins. For each protein analysis, specific primary antibodies were incubated at 4°C overnight (Table 1) . Next, the membranes were washed 4 times with Trisbuffered saline-Tween-20 (TBST) for 10 min each and incubated with the secondary antibodies at room temperature for 1 h (Table 1) . Membranes were washed again 4 times with TBST (10 min each) and finally treated with enhanced chemiluminescence (ECL) reagent (GE Healthcare, Marlborough, MA, USA) for 1 min. ECL-reacted blots were exposed to ChemiDoc (ChemiDoc TM MP Imaging System, Bio-Rad, Hercules, CA, USA) to detect the chemiluminescence signals.
RESULTS
The four donors who provided semen samples on two different occasions were normozoospermic according to the WHO 2010 criteria. Two of the three patients were normozoospermic and one was asthenozoospermic (motility 34%). None of these patients presented with hyperviscous sample. The main goal of our pilot study was to demonstrate the effect of a-chymotrypsin on the expression of sperm functional proteins in hyperviscous samples. In experiment 1, complete degradation of HSPA2 was observed in the hyperviscous donor samples treated with 5 mg of a-chymotrypsin, whereas its expression was prominent in the normally liquefied samples (Fig. 1) .
In experiment 2 in both donor and patient samples, expression profile of sperm surface proteins (HSPA2 and BAG6), membrane-bound protein SPA17, and intracellular proteins (HIST1H2BA, OXPHOS complexes and a-tubulin) revealed the degradation of proteins in the aliquots treated with a-chymotrypsin when compared with the untreated aliquots (Figs. 2&3).
DISCUSSION
At the molecular level, physiological functions of spermatozoa are regulated by proteins, so alterations in their levels will affect sperm function. In the sample aliquots treated with a-chymotrypsin (experiment 2), the expression of all proteins was nondetectable, except SPA17 (20 KDa isoform) that was decreased (Figs. 2 & 3) . A similar change in the expression of cellular proteins has been reported in the mammalian cells (breast cancer cell line MCF-7) treated with 0.05% EDTA-trypsin (Huang et al., 2010) , which exhibits same kind of enzymatic action on the cells.
We analyzed the expression of two surface proteins HSPA2 and BAG6. HSPA2 belongs to the family of heat-shock proteins and is essential not only for the spermatozoa to undergo acrosome reaction, but also for sperm-oocyte recognition and binding (Redgrove et al., 2012; . BAG6 is located in the anterior region of the sperm head and is important to maintain the stability of HSPA2. Knockdown of BAG6 protein influences the decreased expression of HSPA2 (Sasaki et al., 2008) and results in failure of sperm-zona pellucida binding (Bromfield et al., 2015) . In the present study, both HSPA2 and BAG6 proteins were non-detectable in the a-chymotrypsin-treated samples ( Fig. 2A and b) , implying their proteolytic degradation by the enzyme. The absence of these fertility-related proteins might affect the fertilizing ability of the spermatozoa at the molecular level and compromise assisted reproductive techniques (ART) outcome, including in vitro fertilization (IVF) or intrauterine insemination (IUI).
The expression of the mannose-binding protein called sperm protein 17 (SPA17) was also examined. This protein, predominantly present in the fibrous sheath of the tail region and localized to some extent within the cytoplasm of the spermatozoa, is proposed to be a zona pellucida interacting protein (Frayne & Hall, 2002; Chiriva-Internati et al., 2009) . SPA17 is also involved in sperm maturation, capacitation, acrosome reaction, and 
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EFFECT OF a-CHYMOTRYPSIN ON SPERM PROTEINS fertilization process (Chiriva-Internati et al., 2009) . Its N-terminus shares a similar sequence with cAMP-dependent protein kinase A regulatory subunit II (PKA RII), thus interacting with Akinase anchoring proteins (AKAPs) localized in the sperm flagella and having an important role in sperm motility (Frayne & Hall, 2002; Chiriva-Internati et al., 2009) . On the other hand, its C-terminus has an IQ calmodulin-binding motif and the central portion of the protein has carbohydrate binding motifs and plays a likely role in cell-cell adhesion (Wen et al., 1999) . Our results demonstrated a decrease in the expression of SPA17 (20 KDa) in the samples treated with a-chymotrypsin when compared with the untreated samples (Fig. 2C) . In general, the C-terminal calmodulin domain of SPA17 (20 KDa) is proteolytically cleaved to 17 KDa after the acrosome reaction and binds to the extracellular matrix of the oocyte (Ying et al., 2001; Frayne & Hall, 2002) . Under in vitro conditions, cleavage of SPA17 is executed by trypsin, which in turn regulates the downstream signaling pathways by modulating release of calmodulin (Wen et al., 1999) . We also observed a decrease in the expression levels of the native form of SPA17 (20 KDa) as a result of the proteolytic action of a-chymotrypsin. Contrastingly, the spermatozoa treated with a-chymotrypsin revealed complete degradation of the cleaved form (17 KDa) of protein (Fig. 2C) , which might be due to the ability of a-chymotrypsin to cleave at multiple sites. Although this is the first study to illustrate the degradation of SPA17 (17 KDa) in spermatozoa, it is in agreement with another study that showed the complete degradation of purified insulin by a-chymotrypsin when compared with trypsin alone (Schilling & Mitra, 1991) . Expression of testis/sperm-specific nuclear histone HIST1H2BA and four proteins of the mitochondrial OXPHOS-a regulator of sperm motility (Sudjarwo et al., 2012) was also assessed to demonstrate the effect of a-chymotrypsin on protein degradation at intracellular level. Our results showed a complete degradation of HIST1H2BA protein (Fig. 2D ) in semen samples treated with a-chymotrypsin. The nucleoprotein HIST1H2BA is a testis-specific histone involved in chromatin packaging, and its expression was altered in male infertility conditions, such as enhanced oxidative stress and varicocoele that may lead to increased DNA damage (Zini et al., 2008; Sharma et al., 2013; Agarwal et al., 2015) . In fact, a previous report by Chatterjee & Walker (1973) showed that a-chymotrypsin completely degrades deoxyribonucleohistone proteins. It is also reported that hyperviscosity of semen reduces the sperm chromatin integrity (Gopalkrishnan et al., 2000) , thus increasing its susceptibility to damage. Therefore, degradation of HIST1H2BA will expose the sperm DNA making it more vulnerable to fragmentation. On the other hand, a report by Esfandiari et al. (2014) showed that when the hyperviscous samples were liquefied mechanically by the use of 5-mL syringe fitted with a sterile 18G needle, it did not affect the sperm DNA fragmentation rate, thus validating the fact that it is the a-chymotrypsin-induced damage to the nuclear histone that may induce DNA fragmentation in the spermatozoa of hyperviscous sample and not the viscosity. Similarly, using OXPHOS human cocktail (Abcam, Cambridge, MA, USA) antibodies, we identified four proteins of the OXPHOS system (ATP5A, UQCRC, COXII, and NDUFB8) in the untreated control samples, whereas they were totally absent in the treated samples (Fig. 3) . The temperature-sensitive complex II (SDHB) could not be detected as the sample preparation step was carried out at 100°C. Our study demonstrates that a-chymotrypsin not only affects the surface-bound proteins (HSPA2 and BAG6) but also degrades intracellular proteins (HIST1H2BA and OXPHOS complexes). Furthermore, SPA17 is primarily a membrane protein involved in cell-cell interaction and it is also present in soluble fraction of SDS-treated spermatozoa lysates (Wen et al., 1999) . We observed a degradation of SPA17 by a-chymotrypsin. These results demonstrate the deleterious effect of the currently recommended concentration of the enzyme that is available commercially on both intracellular and surface proteins.
Even though there are certain beneficial outcomes of a-chymotrypsin treatment in viscous semen samples, including better liquefaction and increase in sperm motility (Daw et al., 2011) , patients with seminal hyperviscosity demonstrated significantly lower fertilization, implantation, and pregnancy rates (Esfandiari et al., 2008) . These negative effects of a-chymotrypsin on reproductive function may be attributed to the alterations in the expression pattern of sperm proteins that are vital for their normal function. Altogether, analysis of the expression of sperm functional proteins explains the dramatic impact of a-chymotrypsin treatment (Figs. 2 and 3) . A decrease in the expression of a-tubulin, a major component of the cytoskeleton and centrosome of spermatozoa, was observed in the present study (Fig. 2E) . This may be due to the damage induced to the sperm membrane by a-chymotrypsin (Moody et al., 2017) .
Another important aspect addressed by our pilot study is regarding the suitability of the hyperviscous samples treated with a-chymotrypsin for global proteomic studies. The overall decrease in the protein expression suggests that enzymatic action of a-chymotrypsin either degrades or digests the proteins, making the sample unsuitable for further expressional proteomic studies. Therefore, the hyperviscosity of semen samples has to be reduced mechanically or by milder treatment with lower concentrations of a-chymotrypsin for proteomic studies. One of the most important implications of our study is that the spermatozoa obtained by semen processing with a-chymotrypsin may drastically affect the outcome of ART.
One of the limitations of our study is a small sample size, which is related to the small incidence (12-20%) of hyperviscous sample in a population of infertile men. Therefore, most of the protein expression profile examined in our study used normally liquefied semen. Another limitation is the use of a-chymotrypsin at a concentration (5 mg) as recommended by the manufacturer for prescribed incubation period (20 min) at 37°C. A dose-and time-dependent analysis of the effect of chymotrypsin on Figure 3 Effect of treatment of a-chymotrypsin (5 mg, 20 min, 37°C) on expression profile of OXPHOS complexes (ATP5A, UQCRC, COXII, and NDUFB8). C D : control donor; T D : treated donor; C P : control patient; T P : treated patient.
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To the best of our knowledge, this is the first report that describes the significant alterations in sperm proteins, specifically HSPA2, BAG6, SPA17, HIST1H2BA, OXPHOS complexes and a-tubulin after a-chymotrypsin treatment as demonstrated by Western blot analysis. The addition of this enzyme to semen samples degrades the spermatozoal proteins, thereby making their expression non-detectable by immunoblotting. Therefore, spermatozoa recovered from hyperviscous samples after treatment with a-chymotrypsin may affect other sperm functional parameters such as capacitation, acrosome reaction, and DNA fragmentation, thereby affecting ART outcome. This may be especially true in patients undergoing intrauterine insemination where spermatozoa are prepared on a double-density gradient separation to recover the highly motile, morphologically normal spermatozoa for insemination. This however needs further investigation.
